Download Files:
Products Details
Product Description
– HBV-IN-22 (Compound LC5f) is an inhibitor of HBV DNA replication with IC50 values of 0.71 μM and 0.84 μM against wild-type and agent resistant HBV strains, respectively[1].
Web ID
– HY-146394
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C26H29N3O2S2
References
– [1]Qiu J, et al. Discovery of novel quinazolinone derivatives as potential anti-HBV and anti-HCC agents. Eur J Med Chem. 2020 Nov 1;205:112581.
CAS Number
– 2338573-94-5
Molecular Weight
– 479.66
SMILES
– CCN(CCOC1=CC=C2N=C(N(C(C2=C1)=O)CC3=CC=CS3)SCC4=CC=CC=C4)CC
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– DNA/RNA Synthesis;HBV
Pathway
– Anti-infection;Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
